QuicKey Pro Human TFPI (Tissue Factor Pathway Inhibitor) ELISA Kit (E-OSEL-H0048)
Add to cart
For research use only.
Product Summary
Get more sensitive and precise results with saving at least 1-2h comparing to traditional ELISA Kits. The new developed technology in house will help to accelerate your science research in a more efficient way.
Sensitivity | 37.51 pg/mL |
Detection Range | 62.5-4000 pg/mL |
Sample Volume | 50 μL |
Manual Operation Time | 30 min |
Total Assay Time | 1 h 30 min |
Reacitivity | Human |
Specificity | This kit recognizes TFPI in samples.No significant cross-reactivity or interference between TFPI and analogues was observed. |
Recovery | 80%-120% |
Sample Type | Serum, plasma and other biological fluids |
Detection Method | Colorimetric method, ELISA, Sandwich |
Assay Type | Sandwich-ELISA |
Size | 96T / 48T / 24T / 96T*5 / 96T*10 |
Storage | 2-8℃ |
Expiration Date | 6 months |
Test Principle
This ELISA kit uses the Sandwich-ELISA principle. The micro ELISA plate provided in this kit has been pre-coated with an antibody specific to Human TFPI. Samples (or Standards) and Horseradish Peroxidase (HRP) linked antibody specific for Human TFPI are added to the micro ELISA plate wells. Human TFPI in samples (or standards) combines with the coated antibody and HRP linked detection antibody special to Human TFPI.Excess conjugate and unbound sample or standard are washed from the plate. The substrate solution is added to each well. The enzyme-substrate reaction is terminated by the addition of stop solution and the color turns yellow. The optical density (OD) is measured spectrophotometrically at a wavelength of 450 nm ± 2 nm. The OD value is proportional to the concentration of Human TFPI. The concentration of Human TFPI in the samples is then determined by comparing the OD of the samples to the standard curve.
Background
Tissue Factor Pathway Inhibitor (TFPI) is a key regulator of the extrinsic coagulation pathway. It inhibits coagulation through the formation of a quaternary complex with Coagulation Factor X, Coagulation Factor III/Tissue Factor, and Coagulation Factor VII, thereby preventing the activation of Factor X. TFPI also exhibits anti-angiogenic and anti-metastatic effects. It is produced by vascular endothelial cells and circulates as a free molecule, on platelet surfaces, and in complex with LDL and HDL particles. Abnormal TFPI concentrations in the circulation are associated with thrombosis, disseminated intravascular coagulation, and sepsis. TFPI can enhance anti-thrombotic treatment in sepsis, inflammatory diseases, and cardiovascular diseases.
Gene Alias | TFPI |
Gene ID | 7035 |
Uniport ID | P10646 |
Protein Alias | TFPI |
Research Area | Immunology |
Other Clones
1 Results
Other Formats
1 Results